OtherArticle
Overcoming S-Phase Checkpoint-Mediated Resistance: Sequence-Dependent Synergy of Gemcitabine and SN-38 In Human Carcinoma Cell Lines*
Marina Galvez-Peralta, Nga T Dai, Dave A Loegering, Karen Flatten, Stephanie Safgren, Jill Wagner, Matthew M Ames, Larry M Karnitz and Scott H Kaufmann
Molecular Pharmacology May 28, 2008, DOI: https://doi.org/10.1124/mol.108.047787
Marina Galvez-Peralta
Nga T Dai
Dave A Loegering
Karen Flatten
Stephanie Safgren
Jill Wagner
Matthew M Ames
Larry M Karnitz
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Overcoming S-Phase Checkpoint-Mediated Resistance: Sequence-Dependent Synergy of Gemcitabine and SN-38 In Human Carcinoma Cell Lines*
Marina Galvez-Peralta, Nga T Dai, Dave A Loegering, Karen Flatten, Stephanie Safgren, Jill Wagner, Matthew M Ames, Larry M Karnitz and Scott H Kaufmann
Molecular Pharmacology May 28, 2008, DOI: https://doi.org/10.1124/mol.108.047787
OtherArticle
Overcoming S-Phase Checkpoint-Mediated Resistance: Sequence-Dependent Synergy of Gemcitabine and SN-38 In Human Carcinoma Cell Lines*
Marina Galvez-Peralta, Nga T Dai, Dave A Loegering, Karen Flatten, Stephanie Safgren, Jill Wagner, Matthew M Ames, Larry M Karnitz and Scott H Kaufmann
Molecular Pharmacology May 28, 2008, DOI: https://doi.org/10.1124/mol.108.047787
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement